Search results
Cardinal Health, Inc. (NYSE:CAH) Q3 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 day agoCardinal Health, Inc. (NYSE:CAH) Q3 2024 Earnings Call Transcript May 2, 2024Cardinal Health, ...
Unveiling Cardinal Health (CAH)'s Value: Is It Really Priced Rig
Guru Focus· 13 hours agoCardinal Health Inc (CAH, Financial) recently experienced a daily loss of 3.95%, aligning...three-month downturn of 3.97%. Investors ...
Decoding Cardinal Health Inc (CAH): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 2 days agoCOVID-19 vaccine distribution and generics program bolster Pharmaceutical and Specialty Solutions...
Cardinal Health Inc (CAH) Q3 Earnings: Surpasses Analyst EPS Forecasts and Raises FY24 Guidance
GuruFocus.com via Yahoo Finance· 2 days agoPharmaceutical and Specialty Solutions segment revenue rose 9% to $50.7 billion, driven by brand and...
Cardinal Health (CAH) Beats on Q3 Earnings, Ups '24 EPS View
Zacks via Yahoo Finance· 2 days agoCardinal Health's (CAH) third-quarter fiscal 2024 results benefit from solid profit growth in ...
For Cardinal Health, the Proof Will be in Its Performance
MSN News· 1 day agoInvestors are familiar with the phrase "buy the rumor, sell the news." However, Cardinal Health Inc....
Analyst Report: Cardinal Health, Inc.
Morningstar Research via Yahoo Finance· 2 days agoAlong with Cencora and McKesson, the three comprise well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies ...
Cardinal Health Inc (CAH) (Q3 2024) Earnings Call Transcript Highlights: Strong Growth and ...
GuruFocus.com via Yahoo Finance· 1 day agoPharmaceutical and Specialty Solutions Revenue: Increased 9% to $50.7 billion. Pharmaceutical and Specialty Solutions Segment Profit: Increased 4% to...
What's in Store for Cardinal Health (CAH) in Q3 Earnings?
Zacks via Yahoo Finance· 5 days agoCardinal Health's (CAH) third-quarter fiscal 2024 results are expected to reflect solid performance...
Cardinal Health lifts 2024 profit view on demand for costly specialty drugs
Reuters· 2 days ago, opens new tab raised its annual profit forecast on Thursday, betting on strength in its pharmaceutical unit selling costly specialty drugs used to treat complex conditions ...
